As of Aug 18
| -0.09 / -1.40%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 14.00, with a high estimate of 26.00 and a low estimate of 7.00. The median estimate represents a +120.47% increase from the last price of 6.35.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.